Wang, Heming http://orcid.org/0000-0002-1486-7495
Lane, Jacqueline M.
Jones, Samuel E. http://orcid.org/0000-0003-0153-922X
Dashti, Hassan S. http://orcid.org/0000-0002-1650-679X
Ollila, Hanna M.
Wood, Andrew R.
van Hees, Vincent T. http://orcid.org/0000-0003-0182-9008
Brumpton, Ben http://orcid.org/0000-0002-3058-1059
Winsvold, Bendik S. http://orcid.org/0000-0003-4171-8919
Kantojärvi, Katri
Palviainen, Teemu http://orcid.org/0000-0002-7847-8384
Cade, Brian E.
Sofer, Tamar http://orcid.org/0000-0001-8520-8860
Song, Yanwei http://orcid.org/0000-0002-2411-6548
Patel, Krunal
Anderson, Simon G. http://orcid.org/0000-0002-8896-073X
Bechtold, David A. http://orcid.org/0000-0001-8676-8704
Bowden, Jack
Emsley, Richard
Kyle, Simon D.
Little, Max A.
Loudon, Andrew S.
Scheer, Frank A. J. L. http://orcid.org/0000-0002-2014-7582
Purcell, Shaun M.
Richmond, Rebecca C. http://orcid.org/0000-0003-0574-5071
Spiegelhalder, Kai
Tyrrell, Jessica http://orcid.org/0000-0002-9256-6065
Zhu, Xiaofeng
Hublin, Christer
Kaprio, Jaakko A. http://orcid.org/0000-0002-3716-2455
Kristiansson, Kati http://orcid.org/0000-0003-4688-107X
Sulkava, Sonja
Paunio, Tiina
Hveem, Kristian
Nielsen, Jonas B.
Willer, Cristen J. http://orcid.org/0000-0001-5645-4966
Zwart, John-Anker
Strand, Linn B.
Frayling, Timothy M.
Ray, David
Lawlor, Deborah A. http://orcid.org/0000-0002-6793-2262
Rutter, Martin K.
Weedon, Michael N.
Redline, Susan
Saxena, Richa http://orcid.org/0000-0003-2233-1065
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (F32DK102323, R01DK107859, R01DK102696, R01DK105072)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (T32HL007567, K01HL135405)
Article History
Received: 26 November 2018
Accepted: 27 June 2019
First Online: 13 August 2019
Competing interests
: H.O. is a consultant for Jazz Pharmaceuticals, Medix Biochemica, and Roche Holding. K. Kristiansson is a Consultant for Negen Ltd. F.A.J.L.S. has reveived speaker fees from Bayer Healthcare, Sentara Healthcare, Philips, Kellogg Company, Vanda Pharmaceuticals, and Pfizer. M.K.R. has acted as a consultant for Novo Nordisk and Roche Diabetes Care, and also participated in advisory board meetings on their behalf. The remaining authors declare no competing interests.